Published in
Springer (part of Springer Nature), Breast Cancer Research and Treatment, 1(174), p. 27-37, 2018
DOI: 10.1007/s10549-018-5055-9
Links
Tools
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Journal article published in 2018 by
Rafael Caparica 
,
Marco Bruzzone,
Francesca Poggio ,
Marcello Ceppi ,
Evandro de Azambuja,
Matteo Lambertini
,
Marco Bruzzone,
Francesca Poggio ,
Marcello Ceppi ,
Evandro de Azambuja,
Matteo Lambertini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 